Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2015 | 1 |
2016 | 2 |
2017 | 1 |
2018 | 1 |
2020 | 2 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Glycosylation in Indolent, Significant and Aggressive Prostate Cancer by Automated High-Throughput N-Glycan Profiling.
Int J Mol Sci. 2020 Dec 3;21(23):9233. doi: 10.3390/ijms21239233.
Int J Mol Sci. 2020.
PMID: 33287410
Free PMC article.
A risk calculator to inform the need for a prostate biopsy: a rapid access clinic cohort.
Jalali A, Foley RW, Maweni RM, Murphy K, Lundon DJ, Lynch T, Power R, O'Brien F, O'Malley KJ, Galvin DJ, Durkan GC, Murphy TB, Watson RW.
Jalali A, et al. Among authors: murphy k.
BMC Med Inform Decis Mak. 2020 Jul 3;20(1):148. doi: 10.1186/s12911-020-01174-2.
BMC Med Inform Decis Mak. 2020.
PMID: 32620120
Free PMC article.
Item in Clipboard
Improving multivariable prostate cancer risk assessment using the Prostate Health Index.
Foley RW, Gorman L, Sharifi N, Murphy K, Moore H, Tuzova AV, Perry AS, Murphy TB, Lundon DJ, Watson RW.
Foley RW, et al. Among authors: murphy k.
BJU Int. 2016 Mar;117(3):409-17. doi: 10.1111/bju.13143. Epub 2015 May 24.
BJU Int. 2016.
PMID: 25847734
Clinical Trial.
Item in Clipboard
The role of epithelial-mesenchymal transition drivers ZEB1 and ZEB2 in mediating docetaxel-resistant prostate cancer.
Hanrahan K, O'Neill A, Prencipe M, Bugler J, Murphy L, Fabre A, Puhr M, Culig Z, Murphy K, Watson RW.
Hanrahan K, et al. Among authors: murphy k.
Mol Oncol. 2017 Mar;11(3):251-265. doi: 10.1002/1878-0261.12030. Epub 2017 Jan 30.
Mol Oncol. 2017.
PMID: 28133913
Free PMC article.
Item in Clipboard
Integrating biomarkers across omic platforms: an approach to improve stratification of patients with indolent and aggressive prostate cancer.
Murphy K, Murphy BT, Boyce S, Flynn L, Gilgunn S, O'Rourke CJ, Rooney C, Stöckmann H, Walsh AL, Finn S, O'Kennedy RJ, O'Leary J, Pennington SR, Perry AS, Rudd PM, Saldova R, Sheils O, Shields DC, Watson RW.
Murphy K, et al.
Mol Oncol. 2018 Sep;12(9):1513-1525. doi: 10.1002/1878-0261.12348. Epub 2018 Aug 7.
Mol Oncol. 2018.
PMID: 29927052
Free PMC article.
Item in Clipboard
European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators significantly outperform the Prostate Cancer Prevention Trial (PCPT) 2.0 in the prediction of prostate cancer: a multi-institutional study.
Foley RW, Maweni RM, Gorman L, Murphy K, Lundon DJ, Durkan G, Power R, O'Brien F, O'Malley KJ, Galvin DJ, Brendan Murphy T, William Watson R.
Foley RW, et al. Among authors: murphy k.
BJU Int. 2016 Nov;118(5):706-713. doi: 10.1111/bju.13437. Epub 2016 Feb 29.
BJU Int. 2016.
PMID: 26833820
Clinical Trial.
Item in Clipboard
Cite
Cite